![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
亚太地区血尿治疗市场预测至 2028 年 - COVID-19 影响和治疗(药物、疗法等)、适应症(尿路感染、肾结石、尿道炎、血癌、膀胱结石、前列腺癌、膀胱炎、创伤)的区域分析、剧烈运动、多囊肾、子宫内膜异位症和月经)、类型(肉眼血尿、镜下血尿、特发性血尿和慢跑者血尿)、最终用户(医院、诊所和门诊手术中心等)
市场介绍
血尿是一种在尿液中发现血液的疾病。一般来说,尿液中不含红细胞,因此可能会导致严重的问题,还可能导致肾结石、尿路感染和其他遗传性疾病。
此外,血尿的患病率很高预计相关迹象将在预测期内促进市场增长。然而,相关适应症的未确诊病例限制了亚太地区血尿治疗市场的增长。
COVID-19 疫情严重影响了旅游业并造成供应链中断;此外,低收入国家由于医疗基础设施短缺而面临更多挑战。韩国、马来西亚、新加坡、菲律宾和印度已采取限制措施,以防止疾病传播。由于供应链的限制以及制造能力的有限,所有这些因素在短时间内对血尿治疗市场产生了中等程度的影响。 COVID-19患者的肾脏受累可能有多种表现,包括血尿、蛋白尿、脓尿和急性肾损伤(AKI)。据报道,蛋白尿和血尿在 COVID 19 中的患病率高于 AKI。另一方面,AKI 目前是住院 COVID 19 患者的一个令人不安的迹象,也是死亡的主要危险因素。因此,血尿治疗市场受到COVID19的积极影响。
市场概况和动态
亚太地区血尿治疗市场预计将从 2021 年的 2.11 亿美元增至 2028 年的 2.576 亿美元;预计 2021 年至 2028 年复合年增长率为 2.9%。由于慢性适应症患病率上升,医疗保健支出大幅增加。各个经济体的政府正在大力投资改善医疗基础设施。此外,发达经济体的患者逐渐意识到血尿治疗的可能治疗方法和报销情况。血尿是血癌、膀胱癌和肾癌等慢性疾病的最初迹象之一。这些疾病均受到各种健康保险政策的保障,有助于患者轻松治疗并减轻医疗保健的经济负担。因此,提高医疗保健支出和患者对治疗的认识正在推动亚太地区血尿治疗市场的发展。
主要细分市场
从类型来看,肉眼血尿细分市场在2020年亚太血尿治疗市场中占据最大份额。从治疗来看,药物细分市场占据了最大份额。 2020年亚太血尿治疗市场份额最大。从适应症来看,尿路感染细分市场占2020年亚太血尿治疗市场最大份额。从最终用户来看,医院细分市场占2020年亚太血尿治疗市场份额最大。
主要来源和上市公司
准备本亚太地区血尿治疗市场报告时参考的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库,其中其他的。报告中列出的主要公司包括阿斯利康、百时美施贵宝公司、F. HOFFMANN-LA ROCHE LTD.、葛兰素史克公司、杨森制药、默沙东制药公司和默沙东制药公司。 Co., Inc.、Novartis AG、Pfizer Inc.、Sun Pharmaceutical Industries Ltd 和 Boehringer Ingelheim International GmbH。
购买报告的理由
- 了解亚太地区血尿治疗市场格局并确定细分市场可能保证丰厚的回报
- 了解不断变化的市场格局并在竞争中保持领先
- 通过识别最有前景的销售细分市场,有效规划亚太血尿治疗市场的并购和合作伙伴关系
- 通过敏锐而全面的分析,做出明智的业务决策各个细分市场的市场表现
- 获得2021年-2028年基于各个细分市场的亚太血尿治疗市场的市场收入预测
亚太地区血尿治疗市场细分
作者治疗
- 药物
- 疗法
- 其他
按适应症
- 尿路感染
- 肾结石
- 尿道炎
- 血癌
- 膀胱结石
- 前列腺癌
- 膀胱炎
- 外伤
- 剧烈运动
- 多囊肾病
- 子宫内膜异位症
- 月经
按类型
- 肉眼血尿
- 显微镜下血尿
- 特发性血尿
- 慢跑者血尿
最终用户
- 医院
- 诊所
- 门诊手术中心(ASC 的)
- 其他
按国家/地区
- 亚太地区
- 中国
- 日本
- 印度
- 韩国
- 澳大利亚
- 亚太地区其他地区
提及的公司
- 阿斯利康
- 百时美施贵宝公司
- F. HOFFMANN-LA ROCHE LTD.
- 葛兰素史克公司
- 杨森制药
- 默克公司有限公司
- 诺华公司
- 辉瑞公司
- < span>太阳制药工业有限公司
- 勃林格殷格翰国际有限公司
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Hematuria Treatment Market – By Treatment
1.3.2 Asia Pacific Hematuria Treatment Market – By Indication
1.3.3 Asia Pacific Hematuria Treatment Market – By Type
1.3.4 Asia Pacific Hematuria Treatment Market – By End User
1.3.5 Asia Pacific Hematuria Treatment Market – By Country
2. Asia Pacific Hematuria Treatment Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Hematuria Treatment Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific – PEST Analysis
4.3 Experts Opinion
5. Hematuria Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 High Prevalence of Hematuria-Associated Indications
5.1.2 Increasing Awareness About Treatment Options and Improving Healthcare Expenditure
5.2 Market Restraints
5.2.1 Undiagnosed Cases of Associated Indications
5.3 Market Opportunities
5.3.1 Increasing Opportunities for Related Treatments
5.4 Future Trends
5.4.1 Rise in Preference for Advanced Therapies
5.5 Impact Analysis
6. Hematuria Treatment Market – Asia Pacific Analysis
6.1 Asia Pacific Hematuria Treatment Market Revenue Forecast and Analysis
7. Hematuria Treatment Market Revenue and Forecast To 2028 – By Treatment
7.1 Overview
7.2 Asia Pacific Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)
7.3 Drugs
7.3.1 Overview
7.3.2 Drugs: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Therapies
7.4.1 Overview
7.4.2 Therapies: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Others
7.5.1 Overview
7.5.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8. Hematuria Treatment Market Revenue and Forecast To 2028 – By Indication
8.1 Overview
8.2 Asia Pacific Hematuria Treatment Market Share by Indication 2020 & 2028 (%)
8.3 Kidney Stones
8.3.1 Overview
8.3.2 Kidney Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Urinary Tract Infections (UTI)
8.4.1 Overview
8.4.2 Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Urethritis
8.5.1 Overview
8.5.2 Urethritis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Blood Cancer
8.6.1 Overview
8.6.2 Blood Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.7 Bladder Stones
8.7.1 Overview
8.7.2 Bladder Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.8 Prostate Cancer
8.8.1 Overview
8.8.2 Prostate Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.9 Cystitis
8.9.1 Overview
8.9.2 Cystitis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.10 Trauma
8.10.1 Overview
8.10.2 Trauma: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.11 Vigorous Exercise
8.11.1 Overview
8.11.2 Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.12 Polycystic Kidney Disease
8.12.1 Overview
8.12.2 Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.13 Endometriosis
8.13.1 Overview
8.13.2 Endometriosis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.14 Menstruation
8.14.1 Overview
8.14.2 Menstruation: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
9. Hematuria Treatment Market Revenue and Forecast To 2028 – By Type
9.1 Overview
9.2 Asia Pacific Hematuria Treatment Market, By Type 2020 & 2028 (%)
9.3 Macroscopic Hematuria
9.3.1 Overview
9.3.2 Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.4 Microscopic Hematuria
9.4.1 Overview
9.4.2 Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.5 Idiopathic Hematuria
9.5.1 Overview
9.5.2 Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.6 Jogger’s Hematuria
9.6.1 Overview
9.6.2 Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
10. Hematuria Treatment Market Revenue and Forecast To 2028 – By End User
10.1 Overview
10.2 Asia Pacific Hematuria Treatment Market Share by End User 2020 & 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Clinics
10.4.1 Overview
10.4.2 Clinics: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.5 Ambulatory Surgical Centers (ASC’s)
10.5.1 Overview
10.5.2 Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.6 Others
10.6.1 Overview
10.6.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
11. Asia Pacific Hematuria Treatment Market – Geographic Analysis
11.1 Asia Pacific: Hematuria Treatment Market
11.1.1 Overview
11.1.2 Asia Pacific: Hematuria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
11.1.3 Asia Pacific: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
11.1.4 Asia Pacific: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)
11.1.5 Asia Pacific: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.6 Asia Pacific: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.1.7 Asia Pacific: Hematuria Treatment Market, by Country, 2021 & 2028 (%)
11.1.7.1 China: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.1 China: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.2 China: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.3 China: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)
11.1.7.1.4 China: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.7.1.5 China: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.1.7.2 Japan: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.1 Japan: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.2 Japan: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.3 Japan: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)
11.1.7.2.4 Japan: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.7.2.5 Japan: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.1.7.3 India: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.1 India: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.2 India: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.3 India: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)
11.1.7.3.4 India: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.7.3.5 India: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.1.7.4 South Korea: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.4.1 South Korea: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.4.2 South Korea: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
11.1.7.4.3 South Korea: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)
11.1.7.4.4 South Korea: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.7.4.5 South Korea: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.1.7.5 Australia: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.5.1 Australia: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.5.2 Australia: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
11.1.7.5.3 Australia: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)
11.1.7.5.4 Australia: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.7.5.5 Australia: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.1.7.6 Rest of Asia Pacific: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.6.1 Rest of Asia Pacific: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.6.2 Rest of Asia Pacific: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
11.1.7.6.3 Rest of Asia Pacific: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)
11.1.7.6.4 Rest of Asia Pacific: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.7.6.5 Rest of Asia Pacific: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
12. Impact Of COVID-19 Pandemic on Hematuria Treatment Market
12.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
13. Hematuria Treatment Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 AstraZeneca
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Bristol-Myers Squibb Company
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 F. HOFFMANN-LA ROCHE LTD.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 GlaxoSmithKline Plc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Janssen Pharmaceuticals
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck & Co., Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Novartis AG
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Pfizer Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Sun Pharmaceutical Industries Ltd
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Boehringer Ingelheim International GmbH
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 2. Asia Pacific: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)
Table 3. Asia Pacific: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 4. Asia Pacific: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. China: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 6. China: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)
Table 7. China: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. China: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. Japan: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 10. Japan: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)
Table 11. Japan: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 12. Japan: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. India: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 14. India: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)
Table 15. India: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 16. India: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. South Korea: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 18. South Korea: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)
Table 19. South Korea: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 20. South Korea: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Australia: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 22. Australia: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)
Table 23. Australia: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 24. Australia: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25. Rest of Asia Pacific: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 26. Rest of Asia Pacific: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)
Table 27. Rest of Asia Pacific: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 28. Rest of Asia Pacific: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 29. Organic Developments Done by Companies
Table 30. Inorganic Developments Done by Companies
Table 31. Glossary of Terms, Hematuria Treatment Market
LIST OF FIGURES
Figure 1. Hematuria Treatment Market Segmentation
Figure 2. Asia Pacific Hematuria Treatment Market Overview
Figure 3. Macroscopic Hematuria Segment Held the Largest Share of the Type Segment in Hematuria Treatment Market
Figure 4. India to Show Significant Growth During Forecast Period
Figure 5. Asia Pacific Hematuria Treatment Market, Industry Landscape
Figure 6. Asia Pacific PEST Analysis
Figure 7. Hematuria Treatment Market Impact Analysis of Drivers and Restraints
Figure 8. Asia Pacific Hematuria Treatment Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. Asia Pacific Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)
Figure 10. Drugs: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 11. Therapies: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 12. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 13. Asia Pacific Hematuria Treatment Market Share by Indication 2020 & 2028 (%)
Figure 14. Kidney Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 15. Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 16. Urethritis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 17. Blood Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 18. Bladder Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 19. Prostate Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 20. Cystitis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 21. Trauma: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 22. Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 23. Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 24. Endometriosis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 25. Menstruation: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 26. Asia Pacific Hematuria Treatment Market, by Type 2020 & 2028 (%)
Figure 27. Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 28. Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 29. Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 30. Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 31. Asia Pacific Hematuria Treatment Market Share by End User 2020 & 2028 (%)
Figure 32. Hospitals: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 33. Clinics: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 34. Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 35. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 36. Asia Pacific: Hematuria Treatment Market, by Key Country – Revenue (2021) (US$ Million)
Figure 37. Asia Pacific: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 38. Asia Pacific: Hematuria Treatment Market, by Country, 2021 & 2028 (%)
Figure 39. China: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Japan: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. India: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. South Korea: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. Australia: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Rest of Asia Pacific: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Impact Of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 46. Growth Strategies Done by the Companies in the Market, (%)- AstraZeneca
- Bristol-Myers Squibb Company
- F. HOFFMANN-LA ROCHE LTD.
- GlaxoSmithKline plc.
- Janssen Pharmaceuticals
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd
- Boehringer Ingelheim International GmbH
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific hematuria treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific hematuria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.